Prostate cancer is one of the most common malignant tumors in men, both in Israel and across the Western world. Every year, about 2,000 new cases are diagnosed in Israel, and around 500 men die from this disease annually. Prostate cancer typically affects men over the age of 50 and usually progresses slowly.
Although the exact cause is still unknown, environmental factors and diet are believed to play a significant role in the development of prostate cancer.
Today, most patients are diagnosed at an early stage, when the tumor is still localized within the prostate and has not spread. The cancer stage is assessed based on several factors, including the Gleason Score from a biopsy, PSA (prostate-specific antigen) levels in the blood, and physical examination findings. Additional imaging studies, such as bone scintigraphy, CT, and MRI, may also be conducted when needed.
Laparoscopic radical prostatectomy is indicated for patients with localized cancer. During surgery, the entire prostate gland is removed with the goal of complete cure.
